Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study.
Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots K, Chernoff D, Winkler C, O'Brien SJ. Daar ES, et al. Among authors: hoots k. J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):317-25. doi: 10.1097/00126334-199908010-00010. J Acquir Immune Defic Syndr. 1999. PMID: 10428111
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ. Smith MW, et al. Among authors: hoots k. Science. 1997 Aug 15;277(5328):959-65. doi: 10.1126/science.277.5328.959. Science. 1997. PMID: 9252328
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. Carrington M, et al. Among authors: hoots k. Science. 1999 Mar 12;283(5408):1748-52. doi: 10.1126/science.283.5408.1748. Science. 1999. PMID: 10073943
The next generation of hemophilia treatment specialists.
Berntorp E, Gomperts E, Hoots K, Wong WY. Berntorp E, et al. Among authors: hoots k. Semin Thromb Hemost. 2006 Jun;32 Suppl 2:39-42. doi: 10.1055/s-2006-946914. Semin Thromb Hemost. 2006. PMID: 16804835 Review.
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M. Martin MP, et al. Among authors: hoots k. Nat Genet. 2002 Aug;31(4):429-34. doi: 10.1038/ng934. Epub 2002 Jul 22. Nat Genet. 2002. PMID: 12134147
Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1.
Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'brien SJ, Telenti A, Carrington M. Bashirova AA, et al. Among authors: hoots k. J Virol. 2006 Jul;80(14):6757-63. doi: 10.1128/jvi.00094-06. J Virol. 2006. PMID: 16809281 Free PMC article.
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Martin MP, et al. Among authors: hoots k. J Virol. 2004 Dec;78(24):14053-6. doi: 10.1128/JVI.78.24.14053-14056.2004. J Virol. 2004. PMID: 15564514 Free PMC article.
53 results